Matches in Nanopublications for { ?s ?p "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP466753.RAoIkm28QdMh3JhdJsXWtCtTotFM0Mnl_TjdWkDD-7Jgo130_assertion description "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466753.RAoIkm28QdMh3JhdJsXWtCtTotFM0Mnl_TjdWkDD-7Jgo130_provenance.
- NP850660.RARKKCPfYDnhOoqBiHXi6votmq1mxkEYHbgp0oOUHqh3g130_assertion description "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850660.RARKKCPfYDnhOoqBiHXi6votmq1mxkEYHbgp0oOUHqh3g130_provenance.
- NP456492.RAJ2FIUwsPsW__2clRZZy8kKFj9YoRPBU8yVlRqyzT_Js130_assertion description "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456492.RAJ2FIUwsPsW__2clRZZy8kKFj9YoRPBU8yVlRqyzT_Js130_provenance.
- NP771412.RA4R8bhgWp3SW_uUAGdLy_81Uqefcz-5XkI4ekZpolljw130_assertion description "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771412.RA4R8bhgWp3SW_uUAGdLy_81Uqefcz-5XkI4ekZpolljw130_provenance.
- assertion description "[We studied VIIc in 100 patients with chronic renal disease or on maintenance dialysis and examined its relationship with dyslipidaemia, a marker of coagulation activation prothrombin fragment F1+2 (F1+2), the acute-phase reactant and coagulation factor fibrinogen, a mediator of the inflammatory response interleukin-6 (IL6), and the factor VII R353Q polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.